•
AX
AXSM
Axsome Therapeutics, Inc
yahooPHARMACEUTICAL PREPARATIONS
--
Price Chart
Market Cap
9.53B
Volume
1.13M
52W High
$189.34
52W Low
$86.99
Open
$0.00
Prev Close
$184.50
Day Range
0.00 - 0.00
About Axsome Therapeutics, Inc
Axsome Therapeutics Inc is a clinical-stage biopharmaceutical company. It is engaged in developing novel therapies for the management of the central nervous system, or CNS, disorders for which there are limited treatment options. Its pipeline products includes AXS-05, AXS-07, AXS-12, and AXS-14. It manages its business as one operating segment and reporting unit, which is the business of developing and delivering novel therapies for the management of CNS disorders.
Latest News
Biotech Is Heating Up—These 2 Red-Hot Stocks Stand Out
Investing.com•Jan 8
2 Healthcare Stocks to Buy for 2026 and Beyond
The Motley Fool•Jan 8
Axsome Therapeutics Announces FDA Acceptance and Priority Review of Supplemental New Drug Application for AXS-05 for the Treatment of Alzheimer’s Disease Agitation
GlobeNewswire Inc.•Dec 31
2 Under-the-Radar Stocks to Buy Heading Into 2026
The Motley Fool•Dec 2
Axsome Therapeutics to Participate in Upcoming Investor Conferences
GlobeNewswire Inc.•Nov 20
Prediction: These 2 Under-the-Radar Stocks Could Beat the Market in the Next 5 Years
The Motley Fool•Sep 30
Investor Alert: Class Action Lawsuits Against General Motors, DocGo, Estée Lauder, and Axsome Therapeutics Survive Motions to Dismiss — Johnson Fistel, PLLP Encourages Shareholders to Contact the Firm
GlobeNewswire Inc.•Sep 13
Axsome Therapeutics to Participate in Upcoming Investor Conferences
GlobeNewswire Inc.•Aug 27